Pharmaids [PHARMAID] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Pharmaids Pharmaceuticals Limited

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharmaids Pharmaceuticals Limited wins in 4 metrics, Gujarat Themis Biosyn Ltd. wins in 14 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pharmaids Pharmaceuticals Limited Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 2,023.33 73.73 Gujarat Themis Biosyn Ltd.
Price-to-Book Ratio 2.11 13.36 Pharmaids Pharmaceuticals Limited
Debt-to-Equity Ratio 39.24 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio 74.19 -17.55 Pharmaids Pharmaceuticals Limited
EV/EBITDA -7.84 52.76 Gujarat Themis Biosyn Ltd.
Profit Margin (TTM) -54.23% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) -54.88% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) N/A 40.16% N/A
Return on Equity -19.58% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) -8.99% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-264.72M $-251.22M Gujarat Themis Biosyn Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -50.97% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 4.28 22.23 Pharmaids Pharmaceuticals Limited
Enterprise Value $1.29B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 5.05 22.65 Pharmaids Pharmaceuticals Limited
Gross Profit Margin (TTM) 56.76% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $7 $15 Gujarat Themis Biosyn Ltd.
Earnings per Share (Diluted) $-5.13 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.06 -0.17 Gujarat Themis Biosyn Ltd.

Pharmaids Pharmaceuticals Limited vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

PHARMAID
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids Pharmaceuticals Limited-1.88%-2.05%-8.42%-22.03%-45.59%-43.03%
Gujarat Themis Biosyn Ltd.1.72%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids Pharmaceuticals Limited-50.97%1.30%33.07%991.37%692.17%205.54%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Pharmaids Pharmaceuticals Limited vs Gujarat Themis Biosyn Ltd.

MetricPHARMAIDGUJTHEM
Market Information
Market Cap i₹1.09B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,80179,452
90 Day Avg. Volume i13,247106,446
Last Close₹27.18₹401.80
52 Week Range₹25.60 - ₹70.00₹225.05 - ₹479.00
% from 52W High-61.17%-16.12%
All-Time High₹87.46 (Nov 11, 2024)₹479.00 (Oct 27, 2025)
% from All-Time High-68.92%-16.12%
Growth Metrics
Quarterly Revenue Growth0.15%0.10%
Quarterly Earnings Growth0.15%-0.04%
Financial Health
Profit Margin (TTM) i-0.54%0.30%
Operating Margin (TTM) i-0.55%0.40%
Return on Equity (TTM) i-0.20%0.20%
Debt to Equity (MRQ) i39.2427.04
Cash & Liquidity
Book Value per Share (MRQ)₹14.65₹24.29
Cash per Share (MRQ)₹0.07₹0.92
Operating Cash Flow (TTM) i₹-278,094,000₹970.68M
Levered Free Cash Flow (TTM) i₹-107,766,000₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Pharmaids Pharmaceuticals Limited vs Gujarat Themis Biosyn Ltd.

MetricPHARMAID (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i2,023.3373.73
Forward P/E iN/AN/A
PEG Ratio i74.19-17.55
Price to Sales (TTM) i4.2822.23
Price to Book (MRQ) i2.1113.36
Market Capitalization
Market Capitalization i₹1.09B₹35.41B
Enterprise Value i₹1.29B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i5.0522.65
Enterprise to EBITDA i-7.8452.76
Risk & Other Metrics
Beta i0.06-0.17
Book Value per Share (MRQ) i₹14.65₹24.29

Financial Statements Comparison: Pharmaids Pharmaceuticals Limited vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPHARMAID (2025)GUJTHEM (2025)
Revenue/Sales i188.13M1.51B
Cost of Goods Sold i142.75M318.78M
COGS % of Revenue i75.9%21.1%
Gross Profit i45.38M1.19B
Gross Margin i24.1%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i-151.64M642.49M
Operating Margin i-80.6%42.6%
EBITDA i-127.33M713.04M
EBITDA Margin i-67.7%47.3%
Pre-Tax Income i-172.79M655.38M
Pre-Tax Income % of Revenue i-91.8%43.5%
Income Tax i-37.74M167.66M
Income Tax % of Revenue i-20.1%11.1%
Net Income (Profit) i-135.05M487.72M
Profit Margin i-71.8%32.3%

Balance Sheet & Liquidity Metrics

MetricPHARMAID (2025)GUJTHEM (2025)
Cash & Equivalents i21.45M116.94M
Total Current Assets i223.07M519.73M
Total Current Assets % of Revenue i118.6%34.5%
Total Current Liabilities i287.15M205.60M
Total Current Liabilities % of Revenue i152.6%13.6%
Long-Term Debt i331.19M296.36M
Long-Term Debt % of Revenue i176.0%19.7%
Total Shareholders Equity i550.42M2.48B
Retained Earnings i-266.77M2.37B
Retained Earnings % of Revenue i-141.8%157.4%
Property, Plant & Equipment i19.32M411.30M

Cash Flow Statement Comparison

MetricPHARMAID (2025)GUJTHEM (2025)
Operating Cash Flow i-278.09M970.68M
Operating Cash Flow % of Revenue i-147.8%64.4%
Capital Expenditures i-122.62M-1.16B
Free Cash Flow i-264.72M-251.22M
FCF Margin i-140.7%-16.7%
Debt Repayment i-49.10MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i35.27M108.97M
Float Shares i6.95M29.52M
% Held by Insiders i83.97%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i16.03%26.84%

Dividend Analysis & Yield Comparison: Pharmaids Pharmaceuticals Limited vs Gujarat Themis Biosyn Ltd.

MetricPHARMAIDGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025